Brain 'Car Wash' ultrasound trial aims to fight Alzheimer's
NCT ID NCT07573982
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study tests whether a noninvasive ultrasound device can safely help clear waste from the brain in people at risk for Alzheimer's. Fifteen adults with signs of amyloid buildup will receive either real or sham ultrasound sessions over four weeks. The main goal is to check safety and tolerability, while also looking at early signs of cognitive or biomarker improvement.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Ultrasonic Debris Clearance (UDC) device
What this could lead to
If successful, this could point toward a new way to slow or prevent Alzheimer's by helping the brain clear waste.
What could go wrong
This is a very early, small pilot study (15 people) focused only on safety and feasibility. It may not show any benefit, and the device might cause side effects like headaches or imaging changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER S DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Stanford, California, 94305, United States